Compounds > pyrazolo(3,4-d)pyrimidine
Page last updated: 2024-08-24

pyrazolo(3,4-d)pyrimidine and Prostatic Neoplasms

pyrazolo(3,4-d)pyrimidine has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angelucci, A; Bologna, M; Botta, M; Festuccia, C; Gravina, GL; Muzi, P; Schenone, S; Vicentini, C1

Other Studies

1 other study(ies) available for pyrazolo(3,4-d)pyrimidine and Prostatic Neoplasms

ArticleYear
Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells.
    European journal of cancer (Oxford, England : 1990), 2006, Volume: 42, Issue:16

    Topics: Cell Adhesion; Cell Movement; Epidermal Growth Factor; Genes, src; Humans; Male; Prostatic Neoplasms; Pyrazoles; Pyrimidines; Tumor Cells, Cultured

2006